financetom
Business
financetom
/
Business
/
SC directs Fortis Healthcare for details of IHH deal, Singh Bros role by Mar 1
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SC directs Fortis Healthcare for details of IHH deal, Singh Bros role by Mar 1
Feb 24, 2021 5:49 AM

The Supreme Court has asked Fortis Healthcare to submit details on the Rs 4000 crores IHH deal and the "influence" of Singh Bros even after their resignation by March 1.

Share Market Live

NSE

IHH did not proceed with the Rs 3000 crore deal on account of a restraining order from the apex court, "when then was it deemed for by Fortis to proceed with Rs 4,000 crore deal," SC questioned Fortis.

Further, SC asked the healthcare company if the shadow of Singh Brothers overwhelmed the functioning of Fortis even after their exit. Even though the brothers resigned in Feb 2018, they enjoyed controlling stake till March 2018.

To be updated.

First Published:Feb 24, 2021 2:49 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exelixis Says Zanzalintinib, Atezolizumab Combo Improved Survival in Phase 3 Colorectal Cancer Trial
Exelixis Says Zanzalintinib, Atezolizumab Combo Improved Survival in Phase 3 Colorectal Cancer Trial
Jun 23, 2025
04:45 AM EDT, 06/23/2025 (MT Newswires) -- Exelixis ( EXEL ) said Sunday its phase 3 Stellar-303 trial showed a statistically significant overall survival benefit in the combination of zanzalintinib and atezolizumab in patients with a type of metastatic colorectal cancer. The survival rate improvement was observed across all randomized participants compared with regorafenib, the company said. No new safety...
Vertex Pharmaceuticals, Ono Sign License Deal for Povetacicept in Japan, South Korea
Vertex Pharmaceuticals, Ono Sign License Deal for Povetacicept in Japan, South Korea
Jun 23, 2025
04:36 AM EDT, 06/23/2025 (MT Newswires) -- Vertex Pharmaceuticals ( VRTX ) and Ono Pharmaceutical said Monday they signed an exclusive collaboration and license agreement to develop and commercialize Vertex's povetacicept product candidate in Japan and South Korea. Povetacicept is being developed for the treatment of immunoglobulin A nephropathy or IgAN, primary membranous nephropathy or pMN, and other B cell-mediated...
Shift4 Enters Deal to Acquire Payments Platform Smartpay
Shift4 Enters Deal to Acquire Payments Platform Smartpay
Jun 23, 2025
04:32 AM EDT, 06/23/2025 (MT Newswires) -- Shift4 (FOUR) said Sunday it has agreed to acquire payments platform Smartpay for 296.4 million New Zealand dollars ($180 million). The per-share consideration of NZ$1.20 represents a premium of about 47% to Smartpay's 90-trading-day volume weighted average price, the company said. Smartpay provides electronic funds transfer at point-of-sale solutions supporting about 40,000 merchants...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved